BetterLife Pharma (BETRF) Stock Statistics & Valuation Metrics

BetterLife Pharma has a market cap or net worth of $10.62M. The enterprise value is ―.

BetterLife Pharma has 145,494,890 shares outstanding. The number of shares has decreased by -2.65% in one year.

BetterLife Pharma’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of BetterLife Pharma is -3.40. BetterLife Pharma’s PEG ratio is 0.28.

In the last 12 months, BetterLife Pharma had revenue of 0.00 and earned -2.89M in profits. Earnings per share was -0.03.

In the last 12 months, operating cash flow was -2.51M and capital expenditures 0.00, giving a free cash flow of -2.51M billion.

BetterLife Pharma pays an annual dividend of ―, resulting in a dividend yield of ―

BetterLife Pharma upcoming earnings date is Jun 25, 2025, TBA Not Confirmed.

BetterLife Pharma as a current ratio of 0.05, with Debt / Equity ratio of -17.87%

In the past 12 months, BetterLife Pharma has paid 0.00 in taxes.

BetterLife Pharma EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

BetterLife Pharma has $126.31K in cash and marketable securities with C$1.94M in debt, giving a net cash position of $1.82M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for BetterLife Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―